biote Stock (NASDAQ:BTMD)
Previous Close
$2.85
52W Range
$2.31 - $6.70
50D Avg
$2.74
200D Avg
$3.44
Market Cap
$129.44M
Avg Vol (3M)
$121.40K
Beta
1.16
Div Yield
-
BTMD Company Profile
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
BTMD Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
Annual
| Product/Service | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|
| Service Revenue | $4.95M | $2.79M | $1.82M |
| Dietary Supplements | $36.02M | $38.09M | $32.41M |
| Other Service Revenue | $2.27M | $697.00K | - |
| Product Revenue | $192.24M | $182.57M | $163.13M |
| Training Service Revenue | $1.46M | $1.17M | $973.00K |
Latest
Fiscal year ends in Dec 24 | Currency in USD